Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

EGF antibody (Extracellular Domain)

The Rabbit Polyclonal anti-EGF antibody has been validated for WB, IHC, ELISA, IHC (p) and Func. It is suitable to detect EGF in samples from Human.
Catalog No. ABIN205919

Quick Overview for EGF antibody (Extracellular Domain) (ABIN205919)

Target

See all EGF Antibodies
EGF (Epidermal Growth Factor (EGF))

Reactivity

  • 147
  • 89
  • 48
  • 12
  • 12
  • 6
  • 4
  • 1
  • 1
Human

Host

  • 210
  • 35
  • 10
  • 2
  • 2
  • 1
Rabbit

Clonality

  • 213
  • 46
Polyclonal

Conjugate

  • 119
  • 33
  • 20
  • 13
  • 8
  • 6
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
This EGF antibody is un-conjugated

Application

  • 198
  • 83
  • 71
  • 53
  • 53
  • 34
  • 26
  • 26
  • 25
  • 16
  • 15
  • 13
  • 10
  • 8
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Functional Studies (Func)
  • Binding Specificity

    • 45
    • 16
    • 8
    • 7
    • 7
    • 6
    • 6
    • 5
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Extracellular Domain

    Specificity

    Recognizes human Epidermal Growth Factor, a potent stimulator and regulator of the proliferation of epidermal and epithelial cells, expressed by a variety of cells. The effects of EGF are initiated through tyrosine kinase activity, following the binding of EGF to the extracellular domain of the ~170 kD EGF receptor (EGFR), which also binds other EGF-like ligands with high affinity, including TGF-a (transforming growth factor alpha), VGF (vaccinia virus growth factor) and Betacellulin, expressed in the pancreas, small intestine and by certain tumor cells. Receptor activation through EGF binding triggers several signal transduction pathways, including the JAK/STAT and P13K/AKT pathways.

    Purification

    Purified

    Immunogen

    Recombinant human EGF.

    Type of Immunogen: Recombinant protein

    Isotype

    IgG
  • Application Notes

    Approved: ELISA (0.5 - 2 μg/mL), Func (0.25 - 0.35 μg/mL), IHC, IHC-P (0.25 - 1 μg/mL), WB (0.1 - 0.2 μg/mL)

    Usage: Immunohistochemistry: This product requires protein digestion pre-treatment of paraffin sections e. g. trypsin or pronase. Histology Positive Control Tissue: Human skin ELISA: LS-C42950 may be used in an indirect ELISA system or as a capture antibody in a sandwich ELISA for human EGF in combination with LS-C42951 as a detection reagent.

    Comment

    Target Species of Antibody: Human

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Distilled Water. For long term storage the addition of 0.09 % sodium azide is recommended. For functional studies do not add azide.

    Concentration

    Lot specific

    Buffer

    Lyophilized, PBS,  pH 7.4.
  • Target

    EGF (Epidermal Growth Factor (EGF))

    Alternative Name

    EGF

    Background

    Name/Gene ID: EGF

    Synonyms: EGF, Beta-urogastrone, HOMG4, URG, Epidermal growth factor, Pro-epidermal growth factor

    Gene ID

    1950

    Pathways

    NF-kappaB Signaling, RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
You are here:
Chat with us!